Nanomedicine

Displaying 51 - 55 of 55

New hydrogel nanoplatform shrinks tumors in mice

Functionalised nanoparticles are one avenue of drug delivery for chemotherapeutics. However, getting nanoparticles to target the tumor site has proven difficult to do. One method researchers have used to target cancer cells is to create hydrogels made of filamentous bacteriophage (phage) and gold nanoparticles. Peptide binding ligands can be incorporated into the phage portion of the hydrogel that will then target known carcinoma cells.
17th February 2016

'Hybrid' nanocrystals aid targeted drug delivery

Researchers have taken a huge step closer to the engineering of nanoscale devices to aid the delivery of life-saving drug treatments. Research co-leader Professor Dayong Jin at UTS said such minute devices have the potential to be engineered to efficiently and more safely deliver drug treatments directly to the location of diseased cells while helping avoid harm to healthy cells that fall victim to toxic drugs administered by conventional means.
5th February 2016

Light-activated nanoparticles kill 'superbugs'

Light-activated nanoparticles kill 'superbugs'
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder. Antibiotic-resistant bacteria such as Salmonella, E. Coli and Staphylococcus infect some 2m people and kill at least 23,000 people in the United States each year.
21st January 2016


Research programme explores nanomedicine characterisation

CEA-Leti has announced the launch of the European Nano-Characterisation Laboratory (EU-NCL), funded by the European Union’s Horizon 2020 research and innovation programme. Its main objective is to reach a level of international excellence in nanomedicine characterisation for medical indications of cancer, diabetes, inflammatory diseases or infections, and make this accessible to all organisations developing candidate nanomedicines prior to their submission to regulatory agencies.
6th July 2015

NanoKTN Sparks New Nanomedicine Intelligence Start-Up: NanoScientium

The Nanotechnology Knowledge Transfer Network is pleased to announce the foundation of a new start-up company, NanoScientium, resulting from a NanoKTN NanoPharm focus group meeting held last year at the Stevenage Bioscience Catalyst (SBC).
12th February 2014


Nanomedicine documents

Datasheets
Whitepapers

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham
Productronica India 2017
14th September 2017
India Pragati Maidan, New Delhi
Industry of Things World 2017
18th September 2017
Germany Berlin Congress Center